Table of contents

Original Articles

• Weekly cisplatin ± glutathione in relapsed ovarian carcinoma (1 March, 1995)

  N. COLOMBO, S. BINI, D. MICELI, G. BOGLIUN, L. MARZORATI, G. CAVALETTI, F. PARMIGIANI, P. VENTURINO, M. TEDESCHI, L. FRATTOLA, C. BURATTI, C. MANGIONI
• Identification of small areas of solid growth has a strong prognostic impact in differentiated endometrial carcinomas. A histopathologic and morphometric study (1 March, 1995)

  P. ALM, T. GUDMUNDSSON, R. MÅRTENSSON, H. ANDERSON, G. HORVATH, T. HÖGBERG
• Influence of HSP27 and steroid receptor status on provera sensitivity, DNA-ploidy and survival of females with endometrial cancer (1 March, 1995)

  K. S. RAJU, R. J.B. KING, J. KAERN, D. SUMNER, V. M. ABELER, S. MANDALAYA, C. TROPE
• Co-cultivation of ovarian carcinoma cells with dermal fibroblasts induces fibroblast expression of sex steroid receptor transcripts and protein (1 March, 1995)

  F. KOMMOSS, M. KIECHLE-SCHWARZ, A. DUBOIS, J. PFISTERER, D. SPINNER, H. MADJAR, T. BAUKNECHT, A. PFLEIDERER, B. M. KACINSKI
• Detection of c-K-ras point mutation in ovarian cancer

  (1 March, 1995)

  J.-S. PARK, H.-K. KIM, S.-K. HAN, J.-M. LEE, S.-E. NAMKOONG, S.-J. KIM
• Confirmation of the prognostic value of the ECPI-1 score (myometrial invasion, DNA-ploidy and mean shortest nuclear axis) in FIGO stage I endometrial cancer patients with long follow-up (1 March, 1995)

  J. P.A. BAAK, W. P. SNIJDERS, P. J. VAN DIEST, E. ARMEE-HORVÁTH, P. KENEMANS
• The role of the loop electrosurgical excision procedure in the diagnosis and management of early invasive cervical cancer (1 March, 1995)

  A. W. KENNEDY, J. L. BELINSON, S. WIRTH, J. TAYLOR
• In vivo evidence of increased malignant cell proliferation following surgery in ovarian cancer

  (1 March, 1995)

  S. T. KEHOE, D. M. LUESLEY, K. WARD, K. K. CHAN
• An anatomical study of inguinal lymph node topography and clinical implications for the surgical management of vulval cancer (1 March, 1995)

  J. L. NICKLIN, N. F. HACKER, S. W. HEINTZE, M. VAN EIJKEREN, N. J. DURHAM
• Platinum plus cyclophosphamide plus radiotherapy is superior to platinum alone in ‘high-risk’ epithelial ovarian cancer (residual negative and either stage I or II, grade 3, or stage III, any grade) (1 March, 1995)

  P. J. HOSKINS, K. D. SWENERTON, F. WONG, M. F. MANJI, E. M. MCMURTRIE, N. LE, J. PIKE
• Extended radical hysterectomy in early-stage carcinoma of the uterine cervix: tailoring the radicality (1 March, 1995)

  E. SARTORI, L. FALLO, U. A. BIANCHI, S. PECORELLI, B. LA FACE
• What have we achieved in ovarian cancer? A comparison of survivals and resources in two different periods (1 March, 1995)

  K. BERTELSEN, A. KRUHØFFER